Large-scale testing (Phase 3)Study completedNCT00542724
What this trial is testing
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus
Who this might be right for
Type 1 Diabetes Mellitus
Biodel 462